Download 1 INFORMATION RELATING TO FORWARD

INFORMATION RELATING TO FORWARD-LOOKING STATEMENTS
Certain statements included or incorporated by reference in this Annual Report, in other documents we file with or furnish to
the Securities and Exchange Commission (“SEC”), in our press releases, webcasts, conference calls, materials delivered to
shareholders and other communications, are “forward-looking statements” within the meaning of the United States federal
securities laws. All statements other than historical factual information are forward-looking statements, including without
limitation statements regarding: projections of revenue, expenses, profit, profit margins, tax rates, tax provisions, cash flows,
pension and benefit obligations and funding requirements, our liquidity position or other projected financial measures;
management’s plans and strategies for future operations, including statements relating to anticipated operating performance,
cost reductions, restructuring activities, new product and service developments, competitive strengths or market position,
acquisitions and the integration thereof, divestitures, spin-offs, split-offs or other distributions, strategic opportunities, securities
offerings, stock repurchases, dividends and executive compensation; growth, declines and other trends in markets we sell into;
new or modified laws, regulations and accounting pronouncements; regulatory approvals; outstanding claims, legal
proceedings, tax audits and assessments and other contingent liabilities; foreign currency exchange rates and fluctuations in
those rates; general economic and capital markets conditions; the timing of any of the foregoing; assumptions underlying any
of the foregoing; and any other statements that address events or developments that Danaher intends or believes will or may
occur in the future. Terminology such as “believe,” “anticipate,” “should,” “could,” “intend,” “will,” “plan,” “expect,”
“estimate,” “project,” “target,” “may,” “possible,” “potential,” “forecast” and “positioned” and similar references to future
periods are intended to identify forward-looking statements, although not all forward-looking statements are accompanied by
such words. Forward-looking statements are based on assumptions and assessments made by our management in light of their
experience and perceptions of historical trends, current conditions, expected future developments and other factors they believe
to be appropriate. These forward-looking statements are subject to a number of risks and uncertainties, including but not
limited to the risks and uncertainties set forth under “Item 1A. Risk Factors” in this Annual Report.
Forward-looking statements are not guarantees of future performance and actual results may differ materially from the results,
developments and business decisions contemplated by our forward-looking statements. Accordingly, you should not place
undue reliance on any such forward-looking statements. Forward-looking statements speak only as of the date of the report,
document, press release, webcast, call, materials or other communication in which they are made. Except to the extent required
by applicable law, we do not assume any obligation to update or revise any forward-looking statement, whether as a result of
new information, future events and developments or otherwise.
In this Annual Report, the terms “Danaher” or the “Company” refer to Danaher Corporation, Danaher Corporation and its
consolidated subsidiaries or the consolidated subsidiaries of Danaher Corporation, as the context requires. Unless otherwise
indicated, all amounts in this Annual Report refer to continuing operations.
PART I
ITEM 1. BUSINESS
General
Danaher Corporation designs, manufactures and markets professional, medical, industrial and commercial products and
services, which are typically characterized by strong brand names, innovative technology and major market positions.
Danaher’s research and development, manufacturing, sales, distribution, service and administrative facilities are located in
more than 60 countries. Danaher’s business consists of four segments: Life Sciences; Diagnostics; Dental; and Environmental
& Applied Solutions. Danaher strives to create shareholder value primarily through three strategic priorities:
•
enhancing its portfolio in attractive science and technology markets through strategic capital allocation;
•
strengthening its competitive advantage through consistent application of the DANAHER BUSINESS SYSTEM
(“DBS”) tools; and
•
consistently attracting and retaining exceptional talent.
Danaher measures its progress against these strategic priorities over the long-term based primarily on the following financial
metrics:
•
core revenue growth;
•
core operating margin expansion;
1